Protective effect of (-)clausenamide against Aβ-induced neurotoxicity in differentiated PC12 cells

Neuroscience Letters

Volumn 483, Issue 1, 2010, Pages 78-82

  Hu, Jin Feng ^a   Chu, Shi Feng ^a   Ning, Na ^a   Yuan, Yu He ^a   Xue, Wei ^a   Chen, Nai Hong ^a   Zhang, Jun Tian ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

amyloid; ( )Clausenamide; Alzheimer's disease; Apoptosis

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM; CASPASE 3; CLAUSENAMIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RHODAMINE 123;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL DIFFERENTIATION; CELL STRAIN; CELL VIABILITY; CLAUSENA; CLAUSENA LASSIUM; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; PRIORITY JOURNAL; WESTERN BLOTTING;

AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CALCIUM; CASPASE 3; CELL DIFFERENTIATION; LACTAMS; LIGNANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PC12 CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 77956179804     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.07.067     Document Type: Article

References (30)

1. Bachurin S.O. Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease. Med. Res. Rev. 2003, 23:48-88.
2. Canzoniero L.M., Snider B.J. Calcium in Alzheimer's disease pathogenesis: too much, too little or in the wrong place?. J. Alzheimers Dis. 2005, 8:147-154. (discussion 209-215).
3. Chen L., Liu L., Huang S. Cadmium activates MAPK pathway via induction of reactive oxygen species and inhibition of protein phosphatase 2A and 5. Free Radical Biol. Med. 2008, 45:1035-1044.
4. Cowan K.J., Storey K.B. Mitogen-activated protein kinases: new signaling pathways functioning in cellular responses to environmental stress. J. Exp. Biol. 2003, 206:1107-1115.
5. de la Monte S.M., Sohn Y.K., Wands J.R. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J. Neurol. Sci. 1997, 152:73-83.
6. Duan W.Z., Zhang J.T. Effects of (-), (+)clausenamide on anisodine-induced acetylcholine decrease and associated memory deficits in the mouse brain. Acta Pharm. Sin. 1998, 33:259-263.
7. Eckert A., Keil U., Marques C.A., Bonert A., Frev C., Schüssel K., Müller W.E. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. Biochem. Pharmacol. 2003, 66:1627-1634.
8. Giovanni A., Keramaris E., Morris E.J., Hou S.T., O'Hare M., Dyson N., Robertson G.S., Slack R.S., Park D.S. E2F1 mediates death of β-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J. Biol. Chem. 2000, 275:11553-11560.
9. Götz J., David D., Hoerndli F., Ke Y.D., Schonrock N., Wiesner A., Fath T., Bokhari L., Lim Y.A., Deters N., Ittner L.M. Functional genomics dissects pathomechanisms in tauopathies: mitosis failure and unfolded protein response. Neurodegen. Dis. 2008, 5:179-181.
10. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 297:353-356.
11. Harkany T., Abrahám I., Kónya C., Nyakas C., Zarándi M., Penke B., Luiten P.G. Mechanisms of beta-amyloid neurotoxicity: perspectives of pharmacotherapy. Rev. Neurosci. 2000, 11:329-382.
12. Ivins K.J., Ivins J.K., Sharp J.P., Cotman C.W. Multiple pathways of apoptosis in PC12 cells. CrmA inhibits apoptosis induced by beta-amyloid. J. Biol. Chem. 1999, 274:2107-2112.
13. Koriyama Y., Chiba K., Mohri T. Propentofylline protects β-amyloid protein-induced apoptosis in cultured rat hippocampal neurons. Eur. J. Pharmacol. 2003, 458:235-241.
14. Lagranha C.J., Hirabara S.M., Curi R., Pithon-Curi T.C. Glutamine supplementation prevents exercise-induced neutrophil apoptosis and reduces p38 MAPK and JNK phosphorylation and p53 and caspase 3 expression. Cell Biochem. Funct. 2007, 25:563-569.
15. Lai C.S., Yu M.S., Yuen W.H., So K.F., Zee S.Y., Chang R.C. Antagonizing beta-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res. 2008, 1190:215-224.
16. Lee S.Y., Lee J.W., Lee H., Yoo H.S., Yun Y.P., Oh K.W., Ha T.Y., Hong J.T. Inhibitory effect of green tea extract on beta-amyloid-induced PC12 cell death by inhibition of the activation of NF-kappaB and ERK/p38 MAP kinase pathway through antioxidant mechanisms. Brain Res. Mol. Brain Res. 2005, 140:45-54.
17. Li G., Ma R., Huang C., Tang Q., Fu Q., Liu H., Hu B., Xiang J. Protective effect of erythropoietin on beta-amyloid-induced PC12 cell death through antioxidant mechanisms. Neurosci. Lett. 2008, 442:143-147.
18. Liu S.L., Zhang J.T. Effects of naloxone on l-clausenamide-induced long-term potentiation in dentate gyrus of anesthetized rats. Acta Pharmacol. Sin. 1999, 20:112-116.
19. Majno G., Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 1995, 146:3-15.
20. Mei Y., Yuan Z., Song B., Li D., Ma C., Hu C., Ching Y.P., Li M. Activating transcription factor 3 up-regulated by c-Jun NH(2)-terminal kinase/c-Jun contributes to apoptosis induced by potassium deprivation in cerebellar granule neurons. Neuroscience 2008, 151:771-779.
21. Price D.L., Sisodia S.S., Gandy S.E. Amyloid β amyloidosis in Alzheimer's disease. Curr. Opin. Neurol. 1995, 8:268-274.
22. Przygodzki T., Sokal A., Bryszewska M. Calcium ionophore A23187 action on cardiac myocytes is accompanied by enhanced production of reactive oxygen species. Biochim. Biophys. Acta 2005, 1740:481-488.
23. Qin X.Y., Cheng Y., Cui J., Zhang Y., Yu L.C. Potential protection of curcumin against amyloid beta-induced toxicity on cultured rat prefrontal cortical neurons. Neurosci. Lett. 2009, 463:158-161.
24. Tabner B.J., Turnbull S., El-Agnaf O.M.A., Allsop D. Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease. Free Radical Biol. Med. 2002, 32:1076-1083.
25. Tomiyama T., Shoji A., Kataoka K., Suwa Y., Asano S., Kaneko H., Endo N. Inhibition of amyloid beta protein aggregation and neurotoxicity by rifampicin. Its possible function as a hydroxyl radical scavenger. J. Biol. Chem. 1996, 271:6839-6844.
26. Valencia A., Moran J. Reactive oxygen species induce different cell death mechanisms in cultured neurons. Free Radical Biol. Med. 2004, 36:1112-1125.
27. Yamagishi S., Yamada M., Ishikawa Y., Matsumoto T., Ikeuchi T., Hatanaka H. p38 mitogen-activated protein kinase regulates low potassium-induced c-Jun phosphorylation and apoptosis in cultured cerebellar granule neurons. J. Biol. Chem. 2001, 276:5129-5133.
28. Zebrowski D.C., Alcendor R.R., Kirshenbaum L.A., Sadoshima J. Caspase-3 mediated cleavage of MEKK1 promotes p53 transcriptional activity. J. Mol. Cell Cardiol. 2006, 40:605-618.
29. Zhang J.J., Zhang R.F., Meng X.K. Protective effect of pyrroloquinoline quinone against Abeta-induced neurotoxicity in human neuroblastoma SH-SY5Y cells. Neurosci. Lett. 2009, 464:165-169.
30. Zhu X.Z., Li X.Y., Liu J. Recent pharmacological studies on natural products in China. Eur. J. Pharmacol. 2004, 500:221-230.